What is Robert E. Hoffman's role at Esperion Therapeutics, Inc.?

Robert E. Hoffman reports to the SEC as director at Esperion Therapeutics, Inc. (ESPR), according to the latest filing on July 13, 2026. Robert E. Hoffman has also filed as director at FibroBiologics, Inc. (FBLG), director at TuHURA Biosciences, Inc./NV (HURA) and director at Kura Oncology, Inc. (KURA).

How many shares does Robert E. Hoffman own?

After the latest filing that states it, Robert E. Hoffman directly owned 68,902 shares of TuHURA Biosciences, Inc./NV (HURA). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Robert E. Hoffman bought or sold stock recently?

The most recent open-market purchase was on February 15, 2022: bought 55,000 shares of Kintara Therapeutics, Inc. (HURA) for $25.8K at an average of $0.47.

How do I get alerts when Robert E. Hoffman files?

Follow Robert E. Hoffman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

Insiders · ESPR

Robert E. Hoffman

Director at Esperion Therapeutics, Inc. (ESPR) since April 2025

Robert E. Hoffman has filed 18 insider reports with the SEC since June 2021, as director at Esperion Therapeutics, Inc. (ESPR), director at FibroBiologics, Inc. (FBLG) and director at TuHURA Biosciences, Inc./NV (HURA) and at 1 more company. Robert E. Hoffman made no open-market purchases or sales in the last 12 months. The latest filing, on July 13, 2026, reports sale back to the company at Esperion Therapeutics, Inc. (ESPR).

Filings: 18
Companies: 4
Bought on market: $25.8K
Sold on market: None

Companies where Robert E. Hoffman is an insider

Company	Role	Shares held	Bought	Avg buy	Price now	Last filing
ESPR Esperion Therapeutics, Inc.	Directorsince April 2025	0				Jul 13, 2026
FBLG FibroBiologics, Inc.	Directorsince January 2024				$0.9796	Jun 24, 2026
HURA TuHURA Biosciences, Inc./NV	Director	68,902	$25.8K	$0.47	$1.63+247%	Feb 17, 2026
KURA Kura Oncology, Inc.	Director				$7.27	Jun 23, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Robert E. Hoffman with

Other insiders at the same companies

Questions about Robert E. Hoffman

What is Robert E. Hoffman's role at Esperion Therapeutics, Inc.?: Robert E. Hoffman reports to the SEC as director at Esperion Therapeutics, Inc. (ESPR), according to the latest filing on July 13, 2026. Robert E. Hoffman has also filed as director at FibroBiologics, Inc. (FBLG), director at TuHURA Biosciences, Inc./NV (HURA) and director at Kura Oncology, Inc. (KURA).
How many shares does Robert E. Hoffman own?: After the latest filing that states it, Robert E. Hoffman directly owned 68,902 shares of TuHURA Biosciences, Inc./NV (HURA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E. Hoffman bought or sold stock recently?: The most recent open-market purchase was on February 15, 2022: bought 55,000 shares of Kintara Therapeutics, Inc. (HURA) for $25.8K at an average of $0.47.
How do I get alerts when Robert E. Hoffman files?: Follow Robert E. Hoffman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert E. Hoffman (SEC CIK 0001166288). Totals count each trade once, skipping amendments whose original is on file, from Jun 23, 2021 on. View on SEC EDGAR